Trikafta (elexacaftor/tezacaftor/ivacaftor) is generally effective at easing sinus issues in people with cystic fibrosis (CF) who have already…
Articles by Marisa Wexler, MS
Advocates around the globe are gearing up for a variety of events and digital…
A small clinical trial testing Sionna Therapeutics‘ SION-719 as an add-on treatment for cystic fibrosis (CF) — to…
People with cystic fibrosis (CF) taking Trikafta usually report notable improvements in their quality of life — even…
A therapy created using a miniaturized antibody can correct the functionality of the defective CFTR protein in people with…
Among people with cystic fibrosis (CF), certain measures of blood vessel health — especially regarding the aorta, the body’s…
Kidney stones are commonly detected in children with cystic fibrosis (CF), but are often small and do not require…
The European Medicines Agency (EMA) has awarded the early priority medicines designation, known as e-PRIME, to SPL84, an experimental…
Scientists have developed a more precise version of a gene-editing tool, showing that it can correct mutations that cause…
Short-term increases in air pollution can trigger pulmonary exacerbations — disease flares marked by a sudden worsening in lung…